BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11434124)

  • 1. [Arm morbidity after axillary dissection for breast cancer].
    Stahlberg CI; Jørgensen T
    Ugeskr Laeger; 2001 Jun; 163(24):3356-9. PubMed ID: 11434124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
    Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
    Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer.
    Voogd AC; Ververs JM; Vingerhoets AJ; Roumen RM; Coebergh JW; Crommelin MA
    Br J Surg; 2003 Jan; 90(1):76-81. PubMed ID: 12520579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance.
    Leidenius M; Leivonen M; Vironen J; von Smitten K
    J Surg Oncol; 2005 Oct; 92(1):23-31. PubMed ID: 16180231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.
    Nesvold IL; Dahl AA; Løkkevik E; Marit Mengshoel A; Fosså SD
    Acta Oncol; 2008; 47(5):835-42. PubMed ID: 18568481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
    Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
    Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study.
    Sagen A; Kåresen R; Sandvik L; Risberg MA
    Acta Oncol; 2009; 48(8):1111-8. PubMed ID: 19863218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
    Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
    J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection.
    Baron RH; Fey JV; Raboy S; Thaler HT; Borgen PI; Temple LK; Van Zee KJ
    Oncol Nurs Forum; 2002 May; 29(4):651-9. PubMed ID: 12011912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of breast cancer patients after endoscopic axillary lymph node dissection: a prospective analysis of 52 patients.
    Langer I; Kocher T; Guller U; Torhorst J; Oertli D; Harder F; Zuber M
    Breast Cancer Res Treat; 2005 Mar; 90(1):85-91. PubMed ID: 15770531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective evaluation of the morbidity of axillary clearance for breast cancer.
    Duff M; Hill AD; McGreal G; Walsh S; McDermott EW; O'Higgins NJ
    Br J Surg; 2001 Jan; 88(1):114-7. PubMed ID: 11136322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of axillary level I and II lymphnode dissection on the therapy of stage I and II breast cancer.
    Tocchi A; Mazzoni G; Bettelli E; Miccini M; Giuliani A; Cassini D
    Panminerva Med; 2001 Jun; 43(2):103-7. PubMed ID: 11449180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.